XOMA Corp

Price Chart

Risk-Adjusted Performance

Also Listed On

XOMA Corp (XOMA) Price Performance

XOMA Corp (XOMA) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $29.22, up 1.78% from the previous close.

Over the past year, XOMA has traded between a low of $18.76 and a high of $39.72. The stock has gained 38.3% over this period. It is currently 26.4% below its 52-week high.

XOMA Corp has a market capitalization of $354.43M.

About XOMA Corp

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.